Citadel Advisors’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Citadel Advisors’s Portfolio IBDX Stock Details IBDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$787K	Buy	+31,160	New	+$795K	﹤0.01%	8225
2025 Q4	–	Sell	-228,866	Closed	-$5.86M	–	13266
2025 Q3	$5.86M	Sell	228,866 -18,826	-8%	-$478K	﹤0.01%	4064
2025 Q2	$6.26M	Buy	247,692 +19,094	+8%	+$474K	﹤0.01%	3737
2025 Q1	$5.71M	Buy	228,598 +177,910	+351%	+$4.4M	﹤0.01%	3668
2024 Q4	$1.25M	Sell	50,688 -35,130	-41%	-$879K	﹤0.01%	6572
2024 Q3	$2.21M	Buy	85,818 +36,354	+73%	+$918K	﹤0.01%	5346
2024 Q2	$1.21M	Buy	49,464 +20,237	+69%	+$494K	﹤0.01%	6224
2024 Q1	$725K	Sell	29,227 -276,340	-90%	-$6.85M	﹤0.01%	7594
2023 Q4	$7.71M	Buy	305,567 +236,651	+343%	+$5.65M	﹤0.01%	3181
2023 Q3	$1.62M	Buy	+68,916	New	+$1.66M	﹤0.01%	5608

Other funds holding IBDX

ACA

Aptus Capital Advisors Fairhope, Alabama $12.7B AUM 17.41% 1-Year Est. Return

CIA

Capital Investment Advisors Atlanta, Georgia $7.59B AUM 23.38% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CAI

Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return

SIC

Sigma Investment Counselors Northville, Michigan $2.05B AUM 18.42% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Klingman & Associates New York $2.35B AUM 23.18% 1-Year Est. Return

Citadel Advisors's IBDX Position: Q1 2026 in Review

Citadel Advisors opened a new position in iShares iBonds Dec 2032 Term Corporate ETF (IBDX) in Q1 2026: 31,160 shares worth $787K. The stake represents ﹤0.01% of the portfolio and ranks #8225 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in IBDX as recently as Q3 2025.

Citadel Advisors first reported a position in IBDX in Q3 2023 and has held it in 10 quarters since. The position peaked at $7.71M in Q4 2023. 221 funds tracked by Wall St. Rank hold IBDX as of Q1 2026.

Citadel Advisors held 31,160 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $787K as of Q1 2026.
iShares iBonds Dec 2032 Term Corporate ETF was a new Citadel Advisors position in Q1 2026.
iShares iBonds Dec 2032 Term Corporate ETF made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #8225 holding.
Citadel Advisors first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q3 2023 and has held it in 10 quarters since.
Citadel Advisors's iShares iBonds Dec 2032 Term Corporate ETF position peaked at $7.71M in Q4 2023.
221 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.